Shear-stress and wall-stress regulation of vascular remodeling after balloon angioplasty - Effect of matrix metalloproteinase inhibition

被引:54
作者
Wentzel, JJ
Kloet, J
Andhyiswara, I
Oomen, JAF
Schuurbiers, JCH
de Smet, BJGL
Post, MJ
de Kleijn, D
Pasterkamp, G
Borst, C
Slager, CJ
Krams, R
机构
[1] Erasmus Univ, Dept Cardiol EE2369, Thoraxctr, NL-3000 DR Rotterdam, Netherlands
[2] Expt Cardiol Utrecht, Utrecht, Netherlands
关键词
stress; angioplasty; metalloproteinases;
D O I
10.1161/01.CIR.104.1.91
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Constrictive vascular remodeling (VR) is the most significant component of restenosis after balloon angioplasty (PTA). Whereas in physiological conditions VR is associated with normalization of shear stress (SS) and wall stress (WS), after PTA the role of SS and WS in VR is unknown, Furthermore, whereas matrix metalloproteinase inhibition (MMPI) has been shown to modulate VR after PTA, its effect on the SS and WS control mechanisms after PTA is unknown. Methods and Results-PTA was performed in external iliac arteries of 12 atherosclerotic Yucatan pigs, of which 6 pigs (7 vessels) received the MMPI batimastat and 6 pigs (10 vessels) served as controls. Before and after the intervention and at 6-week follow-up, intravascular ultrasound pullback was performed, allowing 3D reconstruction of the treated segment and computational fluid dynamics to calculate the media-bounded area and SS. WS was derived from the Laplace formula. Immediately after PTA, media-bounded area, WS, and SS changed by 20%, 16%, and -49%, respectively, in both groups. VR was predicted by SS and WS. In the control group, SS and WS had been normalized at follow-up with respect to the reference segment. In contrast, for the batimastat group, the SS had been normalized, but. not the WS. The latter is attributed to an increase in wall area at follow-up. Conclusions-Vascular remodeling after PTA is controlled by both SS and WS. MMPI inhibited the WS control system.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 16 条
[1]   BARORECEPTOR CONTROL OF PRESSURE-FLOW RELATIONSHIPS DURING HYPOXEMIA [J].
BAGSHAW, RJ ;
COX, RH ;
KARREMAN, G ;
NEWSWANGER, J .
JOURNAL OF APPLIED PHYSIOLOGY, 1986, 60 (01) :166-175
[2]   Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury [J].
Bassiouny, HS ;
Song, RH ;
Hong, XF ;
Singh, A ;
Kocharyan, H ;
Glagov, S .
CIRCULATION, 1998, 98 (02) :157-163
[3]   Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury [J].
Bendeck, MP ;
Irvin, C ;
Reidy, MA .
CIRCULATION RESEARCH, 1996, 78 (01) :38-43
[4]   ANALYSIS OF CHANGES IN REACTIVITY OF RABBIT ARTERIES AND VEINS 2 WEEKS AFTER INDUCTION OF HYPERTENSION BY COARCTATION OF ABDOMINAL-AORTA [J].
BEVAN, JA ;
BEVAN, RD ;
CHANG, PC ;
PEGRAM, BL ;
PURDY, RE ;
SU, C .
CIRCULATION RESEARCH, 1975, 37 (02) :183-190
[5]  
CHO YI, 1991, BIORHEOLOGY, V28, P241
[6]   Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty - A study in the atherosclerotic yucatan micropig [J].
de Smet, BJGL ;
de Kleijn, D ;
Hanemaaijer, R ;
Verheijen, JH ;
Robertus, L ;
van der Helm, YJM ;
Borst, C ;
Post, MJ .
CIRCULATION, 2000, 101 (25) :2962-2967
[7]   The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling [J].
de Smet, BJGL ;
van der Zande, J ;
van der Helm, YJM ;
Kuntz, RE ;
Borst, C ;
Post, MJ .
CARDIOVASCULAR RESEARCH, 1998, 39 (01) :224-232
[8]   INTIMAL HYPERPLASIA, VASCULAR MODELING, AND THE RESTENOSIS PROBLEM [J].
GLAGOV, S .
CIRCULATION, 1994, 89 (06) :2888-2891
[9]   Evaluation of endothelial shear stress and 3D geometry as factors determining the development of atherosclerosis and remodeling in human coronary arteries in vivo - Combining 3D reconstruction from angiography and IVUS (ANGUS) with computational fluid dynamics [J].
Krams, R ;
Wentzel, JJ ;
Oomen, JAF ;
Vinke, R ;
Schuurbiers, JCH ;
deFeyter, PJ ;
Serruys, PW ;
Slager, CJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :2061-2065
[10]  
LANGILLE BL, 1993, J CARDIOVASC PHARM, V21, pS11